Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction

William A. Fisher; Ilan Gruenwald; Emmanuele A. Jannini; Ahinoam Lev-Sagie; Lior Lowenstein; Robert E. Pyke; Yakov Reisman; Dennis A. Revicki; Eusebio Rubio-Aurioles

doi:10.1016/j.jsxm.2016.09.022

Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction

William A. Fisher, Ilan Gruenwald, Emmanuele A. Jannini, Ahinoam Lev-Sagie, Lior Lowenstein, Robert E. Pyke, Yakov Reisman, Dennis A. Revicki, Eusebio Rubio-Aurioles

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The focus of this article, the fourth in the series, Standards for Clinical Trials in Male and Female Sexual Dysfunction, is on aspects of clinical trial design and measurement that are specific to clinical trials for treatments of female sexual dysfunction. Challenges in this area include the limited extent of treatment development and clinical trial research across the spectrum of female sexual dysfunctions, changing regulatory considerations, changing diagnostic criteria for female sexual dysfunction, and the need to articulate assessment procedures to these changes. Discussion focuses on approaches to addressing these challenges in clinical trials in female sexual dysfunction.

Original language	English
Pages (from-to)	19-26
Number of pages	8
Journal	Journal of Sexual Medicine
Volume	14
Issue number	1
DOIs	https://doi.org/10.1016/j.jsxm.2016.09.022
State	Published - 1 Jan 2017
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2016 International Society for Sexual Medicine

Keywords

Clinical Trials
Female Sexual Dysfunction
Standards

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jsxm.2016.09.022

Cite this

@article{75a8b65b2eab40d7b62c86608dd0f44d,

title = "Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction",

abstract = "The focus of this article, the fourth in the series, Standards for Clinical Trials in Male and Female Sexual Dysfunction, is on aspects of clinical trial design and measurement that are specific to clinical trials for treatments of female sexual dysfunction. Challenges in this area include the limited extent of treatment development and clinical trial research across the spectrum of female sexual dysfunctions, changing regulatory considerations, changing diagnostic criteria for female sexual dysfunction, and the need to articulate assessment procedures to these changes. Discussion focuses on approaches to addressing these challenges in clinical trials in female sexual dysfunction.",

keywords = "Clinical Trials, Female Sexual Dysfunction, Standards",

author = "Fisher, {William A.} and Ilan Gruenwald and Jannini, {Emmanuele A.} and Ahinoam Lev-Sagie and Lior Lowenstein and Pyke, {Robert E.} and Yakov Reisman and Revicki, {Dennis A.} and Eusebio Rubio-Aurioles",

note = "Publisher Copyright: {\textcopyright} 2016 International Society for Sexual Medicine",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/j.jsxm.2016.09.022",

language = "אנגלית",

volume = "14",

pages = "19--26",

journal = "Journal of Sexual Medicine",

issn = "1743-6095",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Standards for Clinical Trials in Male and Female Sexual Dysfunction

T2 - IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction

AU - Fisher, William A.

AU - Gruenwald, Ilan

AU - Jannini, Emmanuele A.

AU - Lev-Sagie, Ahinoam

AU - Lowenstein, Lior

AU - Pyke, Robert E.

AU - Reisman, Yakov

AU - Revicki, Dennis A.

AU - Rubio-Aurioles, Eusebio

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The focus of this article, the fourth in the series, Standards for Clinical Trials in Male and Female Sexual Dysfunction, is on aspects of clinical trial design and measurement that are specific to clinical trials for treatments of female sexual dysfunction. Challenges in this area include the limited extent of treatment development and clinical trial research across the spectrum of female sexual dysfunctions, changing regulatory considerations, changing diagnostic criteria for female sexual dysfunction, and the need to articulate assessment procedures to these changes. Discussion focuses on approaches to addressing these challenges in clinical trials in female sexual dysfunction.

AB - The focus of this article, the fourth in the series, Standards for Clinical Trials in Male and Female Sexual Dysfunction, is on aspects of clinical trial design and measurement that are specific to clinical trials for treatments of female sexual dysfunction. Challenges in this area include the limited extent of treatment development and clinical trial research across the spectrum of female sexual dysfunctions, changing regulatory considerations, changing diagnostic criteria for female sexual dysfunction, and the need to articulate assessment procedures to these changes. Discussion focuses on approaches to addressing these challenges in clinical trials in female sexual dysfunction.

KW - Clinical Trials

KW - Female Sexual Dysfunction

KW - Standards

UR - http://www.scopus.com/inward/record.url?scp=85021859059&partnerID=8YFLogxK

U2 - 10.1016/j.jsxm.2016.09.022

DO - 10.1016/j.jsxm.2016.09.022

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 28065357

AN - SCOPUS:85021859059

SN - 1743-6095

VL - 14

SP - 19

EP - 26

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

IS - 1

ER -

Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this